MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.22)
Consensus Price Target: $12.81 (315.99% upside)

Analysts' Ratings History for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Cantor FitzgeraldReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016RBC CapitalReiterated RatingSector Perform$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Morgan StanleyReiterated RatingUnderweight$9.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannBoost Price TargetMarket Perform$8.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Jefferies GroupReiterated RatingHold$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015OppenheimerReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Credit SuisseInitiated CoverageNeutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014JPMorgan Chase & Co.Reiterated RatingHold$13.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for ImmunoGen (NASDAQ:IMGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/29/2016        
4/29/2016Q316($0.31)($0.37)$23.02 million$19.71 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2016Q216($0.36)($0.38)$17.87 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q116($0.35)($0.39)$15.84 million$14.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2015Q415($0.34)($0.35)$15.42 million$12.61 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015Q315($0.25)($0.25)$20.95 million$11.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015Q215($0.04)$0.16$37.30 million$48.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2014Q115($0.15)($0.26)$21.80 million$13.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014Q414($0.32)($0.83)$9.72 million$5.74 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2014Q314($0.27)($0.44)$13.28 million$6.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q214($0.18)($0.29)$18.16 million$30.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2013Q114($0.23)($0.13)$12.10 million$17.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013Q4 2013($0.30)($0.26)$3.44 million$3.83 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2013Q3 2013($0.15)($0.02)$11.94 million$25.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2013Q2 2013($0.25)($0.29)$6.02 million$2.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2012Q113($0.25)($0.30)$4.10 million$4.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2012($0.30)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2012($0.26)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2012($0.22)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.22)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011($0.24)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for ImmunoGen (NASDAQ:IMGN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.38)($0.38)($0.38)
Q2 20163($0.38)($0.36)($0.37)
Q4 20161($0.42)($0.42)($0.42)
(Data provided by Zacks Investment Research)
Dividend History for ImmunoGen (NASDAQ:IMGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for ImmunoGen (NASDAQ:IMGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016John LambertEVPSell3,889$8.22$31,967.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Richard J GregoryVPSell2,369$11.10$26,295.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Daniel M. JuniusCEOSell5,416$13.17$71,328.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016John LambertEVPSell3,889$13.20$51,334.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Daniel M. JuniusCEOSell5,416$13.11$71,003.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015John LambertEVPSell3,889$13.11$50,984.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Charles Q MorrisVPSell5,170$14.00$72,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Dean J MitchellDirectorBuy10,000$12.51$125,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Daniel M. JuniusCEOSell5,497$12.00$65,964.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015John LambertEVPSell3,889$11.73$45,617.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Daniel M. JuniusCEOSell5,335$12.01$64,073.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015John LambertEVPSell3,889$9.55$37,139.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015David Brannon JohnstonCFOSell5,000$15.00$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Daniel M. JuniusCEOSell5,416$13.15$71,220.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015John LambertEVPSell3,889$13.16$51,179.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Daniel M JuniusCEOSell5,416$14.34$77,665.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015John LambertEVPSell3,888$14.34$55,753.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Nicole OnettoDirectorSell3,211$13.86$44,504.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015John LambertEVPSell15,000$11.78$176,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Daniel M JuniusCEOSell1,215$8.02$9,744.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015John LambertEVPSell10,000$8.32$83,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Charles Q MorrisVPSell5,240$10.40$54,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Daniel JuniusCEOSell15,000$16.40$246,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2014Charles MorrisVPSell6,936$17.35$120,339.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Charles MorrisVPSell13,672$17.10$233,791.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Daniel JuniusCEOSell15,000$16.26$243,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014John LambertEVPSell4,375$14.90$65,187.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Charles MorrisVPSell7,138$17.00$121,346.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Theresa WingroveVPSell6,250$15.04$94,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014John LambertEVPSell4,375$14.53$63,568.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Daniel JuniusCEOSell15,000$15.11$226,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013John LambertEVPSell4,375$14.70$64,312.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Charles MorrisVPSell12,500$13.75$171,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013John LambertEVPSell4,375$16.41$71,793.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Gregory D PerryCFOSell18,337$17.82$326,765.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Daniel JuniusCEOSell16,667$16.43$273,838.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013John LambertEVPSell4,375$16.45$71,968.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Daniel M JuniusCEOSell16,667$19.21$320,173.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013John LambertEVPSell4,375$19.21$84,043.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013James J O'learyVPSell35,000$19.02$665,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Daniel M JuniusCEOSell16,667$17.31$288,505.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013John LambertEVPSell4,375$16.80$73,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013John LambertEVPSell11,250$17.20$193,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013James J O'learyVPSell28,900$18.11$523,379.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2013John LambertEVPSell11,250$15.56$175,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2013James J O'learyVPSell31,100$17.37$540,207.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/8/2012Mark Alan GoldbergDirectorBuy3,000$11.27$33,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for ImmunoGen (NASDAQ:IMGN)
DateHeadline
06/30/16 07:30 AMDoes ImmunoGen, Inc. Have Any Gas After Today's Huge Decline? - Press Telegraph
06/29/16 04:00 AMThe Montana Tile Worker Who Fought Daughter’s Rare Kidney Cancer -
06/24/16 04:40 PMAnalyst Rating Fluctuations to Observe: Abbott Laboratories (NYSE:ABT) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
06/24/16 04:40 PMStock in Oversold Area: ImmunoGen, Inc. (NASDAQ:IMGN) - Press Telegraph
06/24/16 07:14 AMImmunoGen, Inc. (NASDAQ:IMGN) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 07:14 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During June 22 Session - Equities.com
06/23/16 07:32 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During June 21 Session - Equities.com
06/22/16 09:17 AMImmunoGen, Inc. (NASDAQ:IMGN) Current Analyst Ratings - Fiscal Standard
06/20/16 04:02 PMIMMUNOGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati -
06/20/16 09:52 AMThis Weeks Broker Views For ImmunoGen, Inc. (NASDAQ:IMGN) - Fiscal Standard
06/17/16 07:20 AMMylan NV (NASDAQ:MYL) & ImmunoGen, Inc. (NASDAQ:IMGN) Healthcare Stocks in Focus - Wall Street 24
06/17/16 07:19 AMImmunoGen Inc. (IMGN) is Trading Higher on Unusual Volume for June 15 - Equities.com
06/17/16 07:19 AMStocks Recommendation Update: AbbVie Inc. (NYSE:ABBV) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates
06/16/16 08:53 AMWhy is ImmunoGen (IMGN) Stock Down Today?
06/15/16 04:40 PMHC Stocks in the Rumor: ImmunoGen, Inc. (NASDAQ:IMGN), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - share market updates (press release)
06/15/16 04:40 PMEarnings Analysis to Watch: Symantec Corporation (NASDAQ:SYMC), ImmunoGen, Inc. (NASDAQ:IMGN) - Beacon Chronicle
06/15/16 04:40 PMWhy ImmunoGen, Inc. Noted a Lower Price Today - Motley Fool
06/15/16 04:40 PMImmunoGen Inc. (IMGN) Drops 29.49% on June 14 - Equities.com
06/15/16 04:40 PMImmunoGen Inc. (IMGN) Plunged To A New Low On Offering News - RTT News
06/15/16 09:14 AMSynchrony Financial, Wells Fargo, Navistar slip
06/15/16 09:14 AMBiggest Stocks in Manufacturing at the Close
06/15/16 09:14 AMImmunoGen Inc. (IMGN) Plunged To A New Low On Offering News
06/15/16 08:48 AMBRIEF-ImmunoGen announces pricing of $100 mln offering of Senior Notes - * Sale of notes is expected to result in $96.7 million net proceeds to Immunogen
06/15/16 08:09 AMImmunoGen Announces Pricing of $100 Million Offering of 4.50% Convertible Senior Notes Due 2021 - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (NASDAQ: IMGN) today announced the pricing of $100 million aggregate principal amount of its 4.50% convertible senior notes due 2021 (the 'Notes') in a ...
06/14/16 04:27 PMAnalyst Overview: Pattern Energy Group Inc. (NASDAQ:PEGI), ImmunoGen, Inc. (NASDAQ:IMGN) - Beacon Chronicle
06/14/16 01:15 PMWhy ImmunoGen, Inc. Noted a Lower Price Today - A capital raise could lead to shareholder dilution.
06/14/16 09:27 AMImmunoGen Inc. (IMGN) Is Down After Offering Announcement - RTT News
06/13/16 04:20 PMImmunogen (IMGN) Announces $100M Conv. Senior Note Offering
06/13/16 04:20 PMImmunoGen Inc. (IMGN) Is Down After Offering Announcement
06/13/16 04:01 PMBRIEF-Immunogen announces proposed $100 mln offering of convertible senior notes - * Immunogen announces proposed $100 million offering of convertible senior notes due 2021
06/13/16 03:29 PMImmunoGen Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2021 - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (NASDAQ: IMGN) today announced its intention to offer and sell to the initial purchasers, subject to market and other conditions, $100 million aggregate ...
06/13/16 07:25 AMHC Stocks in Top Row: ImmunoGen, Inc. (NASDAQ:IMGN), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release)
06/11/16 04:42 PMImmunoGen Inc. (IMGN) Drops 5.23% on June 09 - Equities.com
06/11/16 07:22 AMImmunoGen, Inc. Stock Momentum Hits Extreme Weakness - CML News
06/10/16 07:24 AMImmunoGen Inc. (IMGN) Hits New 52-week Low During June 08 Session - Equities.com
06/09/16 04:49 PMImmunoGen, Inc. (NASDAQ:IMGN) Fundamental Star Rating Report - CML News
06/09/16 04:49 PMImmunoGen, Inc. (NASDAQ:IMGN) Fundamental Star Rating Report - CML News
06/09/16 04:49 PMEarnings Report: Kite Pharma, Inc. (NASDAQ:KITE), ImmunoGen, Inc. (NASDAQ:IMGN) - Beacon Chronicle
06/09/16 04:49 PMEarnings Report: Kite Pharma, Inc. (NASDAQ:KITE), ImmunoGen, Inc. (NASDAQ:IMGN) - Beacon Chronicle
06/08/16 07:22 AMThis Hot Stock is Trending: ImmunoGen, Inc. (NASDAQ:IMGN) - News Oracle
06/06/16 04:34 PMAnalysis under consideration: ImmunoGen, Inc. (NASDAQ:IMGN) - News Oracle
06/03/16 04:57 PMStock's Earnings Activity: ImmunoGen, Inc. (NASDAQ:IMGN), Zafgen, Inc. (NASDAQ:ZFGN) - Beacon Chronicle
06/03/16 01:24 PMMoving FORWARD Sends ImmunoGen, Inc. Backwards in May - ImmunoGen hits the brakes on its original study design for its lead experimental drug.
06/03/16 07:17 AMImmunoGen, Inc. (NASDAQ:IMGN) Set To Release Quarterly Earnings - Investor Newswire - ImmunoGen, Inc. (NASDAQ:IMGN) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, ImmunoGen, Inc. (NASDAQ:IMGN) is projected to report earnings of $-0.38 for its recent quarter. The company plans to release its quarterly report on or around 2016-07-29. It should be ...and more »
06/03/16 07:17 AMHealthcare Stocks in Target: Allergan plc. (NYSE:AGN) , ImmunoGen, Inc. (NASDAQ:IMGN) - Is stories - Is storiesHealthcare Stocks in Target: Allergan plc. (NYSE:AGN) , ImmunoGen, Inc. (NASDAQ:IMGN)Is storiesShares of ImmunoGen, Inc. (NASDAQ:IMGN) climbed +7.48% and ended at $6.18 greater than previous closing price of $5.75. The total 1.68 million shares were bought and sold throughout the most recent trading session more than average volume of 1.33 ...and more »
06/02/16 04:51 PMStocks Analysts Ranking Summary: Relypsa, Inc. (NASDAQ:RLYP) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates - Stocks Analysts Ranking Summary: Relypsa, Inc. (NASDAQ:RLYP) , ImmunoGen, Inc. (NASDAQ:IMGN)Street UpdatesOn 6/1/2016, shares of Relypsa, Inc. (NASDAQ:RLYP) rose +3.98% in trading session and finally closed at $19.86. The company most recent volume stood at 5.6 million shares as compared to average volume of 2.74 million shares. Over the one year trading ...and more »
06/02/16 04:51 PMImmunoGen Inc. (IMGN) Jumps 7.48% on June 02 - Equities.com - ImmunoGen Inc. (IMGN) Jumps 7.48% on June 02Equities.comImmunoGen Inc. (IMGN) was among the biggest gainers on the Russell 2000 for Thursday June 02 as the stock popped 7.48% to $6.18, representing a gain of $0.43 per share. Some 1.68 million shares traded hands on 9,974 trades, compared with an ...and more »
06/02/16 07:22 AMBuy, Sell Or Hold Rating For ImmunoGen, Inc. (NASDAQ:IMGN)? - Share Trading News - Buy, Sell Or Hold Rating For ImmunoGen, Inc. (NASDAQ:IMGN)?Share Trading News02/01/2016 – ImmunoGen, Inc. had its “market perform” rating reiterated by analysts at Cowen. They now have a USD 8.5 price target on the stock. 12/03/2015 – ImmunoGen, Inc. had its “hold” rating reiterated by analysts at Jefferies. They now have a USD ...and more »
06/01/16 04:55 PMAnalysts Suggestion Alert: Exelixis, Inc. (NASDAQ:EXEL) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates - Analysts Suggestion Alert: Exelixis, Inc. (NASDAQ:EXEL) , ImmunoGen, Inc. (NASDAQ:IMGN)Street UpdatesOn 5/31/2016, Exelixis, Inc. (NASDAQ:EXEL) ended trading session higher at $6.49 with +2.37%. The company traded a volume of 5.41 million shares as comparison to average volume of 5 million shares. During the 52 –week period, the stock's price traded ...and more »
06/01/16 04:55 PMAnalysts Suggestion Alert: Exelixis, Inc. (NASDAQ:EXEL) , ImmunoGen, Inc. (NASDAQ:IMGN) - Street Updates - Analysts Suggestion Alert: Exelixis, Inc. (NASDAQ:EXEL) , ImmunoGen, Inc. (NASDAQ:IMGN)Street UpdatesOn 5/31/2016, Exelixis, Inc. (NASDAQ:EXEL) ended trading session higher at $6.49 with +2.37%. The company traded a volume of 5.41 million shares as comparison to average volume of 5 million shares. During the 52 –week period, the stock's price traded ...and more »
About ImmunoGen

ImmunoGen logoImmunoGen, Inc. (ImmunoGen) is a clinical-stage biotechnology company focused on the development of targeted anticancer therapeutics. The Company's clinical and preclinical product candidates are antibody-drug conjugates (ADCs), which is a type of medicine that uses a monoclonal antibody to deliver a therapeutic agent to targeted cells. The Company has three clinical-stage anticancer compounds: mirvetuximab soravtansine (IMGN853), coltuximab ravtansine, IMGN529, and IMGN779. The Company's partners are Amgen Inc., Bayer HealthCare (a subgroup of Bayer AG), Biotest AG, Eli Lilly and Company (Lilly), Novartis Institutes for BioMedical Research, Inc. (Novartis), the Roche Group, Sanofi and Takeda. The Company's collaborative partner compounds include Kadcyla, Indatuximab ravtansine, Isatuximab, Anetumumab ravtansine, AMG 595, AMG 172, SAR566658, SAR408701, LOP628 and PCA062. All of the Company's compounds are ADCs with the exception of isatuximab, which is a therapeutic antibody.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IMGN
  • CUSIP: 45253H10
Key Metrics:
  • Previous Close: $3.18
  • 50 Day Moving Average: $4.78
  • 200 Day Moving Average: $7.95
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $272.55M
  • Current Quarter EPS Consensus Estimate: $-1.54 EPS
Additional Links:
ImmunoGen (NASDAQ:IMGN) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha